Vol. 65 No. 3 (2019), ORIGINAL ARTICLES. A. PROTOCOLS OF CLINICAL RESEARCH

Vol. 65 No. 3 (2019)

COMBINED TREATMENT OF LOCALLY ADVANCED NONSMALL CELL LUNG CANCER AND MOLECULAR ASPECTS OF CHEMORESISTANCE

ORIGINAL ARTICLES. A. PROTOCOLS OF CLINICAL RESEARCH

https://doi.org/10.37469/0507-3758-2019-65-3-393-398

Published 01.03.2019

Sergey Miller⁺⁻
Yevgeniy Rodionov⁺⁻
Sergey Tuzikov⁺⁻
Leonid Yefteev⁺⁻
Yevgeniy Yumov⁺⁻
Matvey Tsyganov⁺⁻
Nikolay Litvyakov⁺⁻
Irina Frolova⁺⁻
Nadezhda Cherdyntseva⁺⁻
Svetlana Velichko⁺⁻
Aleksey Goldberg⁺⁻

Sergey Miller

Cancer Research Institute, Tomsk NRMC

Yevgeniy Rodionov

Cancer Research Institute, Tomsk NRMC, Siberian State Medical University

Sergey Tuzikov

Cancer Research Institute, Tomsk NRMC, Siberian State Medical University

Leonid Yefteev

Cancer Research Institute, Tomsk NRMC

Yevgeniy Yumov

Buryat Republican oncological dispensary

Matvey Tsyganov

Cancer Research Institute, Tomsk NRMC

Nikolay Litvyakov

Cancer Research Institute, Tomsk NRMC, National Research Tomsk State University

Irina Frolova

Cancer Research Institute, Tomsk NRMC

Nadezhda Cherdyntseva

Cancer Research Institute, Tomsk NRMC, National Research Tomsk State University

Svetlana Velichko

Cancer Research Institute, Tomsk NRMC

Aleksey Goldberg

Cancer Research Institute, Tomsk NRMC

PDF (Русский)

Keywords

COMBINED TREATMENT
NON-SMALL CELL LUNG CANCER
NEOADJUVANT CHEMOTHERAPY
CHEMORESISTANCE
MONORESISTANCE GENES
ABC-TRANSPORTERS

How to Cite

Miller, S., Rodionov, Y., Tuzikov, S., Yefteev, L., Yumov, Y., Tsyganov, M., Litvyakov, N., Frolova, I., Cherdyntseva, N., Velichko, S., & Goldberg, A. (2019). COMBINED TREATMENT OF LOCALLY ADVANCED NONSMALL CELL LUNG CANCER AND MOLECULAR ASPECTS OF CHEMORESISTANCE. Voprosy Onkologii, 65(3), 393–398. https://doi.org/10.37469/0507-3758-2019-65-3-393-398

Abstract

We analyzed the results of treatment of 68 patients with NSCLC stage III, of which the main group included 36 patients with perioperative chemotherapy vinorelbin / carboplatin. The control group included 32 patients who underwent only surgical treatment. The correlation of monoresistance and multidrug resistance (MDR) genes expression with clinical and morphological parameters of tumor process and with the frequency of distant metastasis was studied. Results. The three - year relapse-free and overall survival in the study group was 60.0±13.8% and 80.0±8.5 %, in the control group-35.7±25.4% and 50.0±18.9%, respectively. The relationship between the expression genes of the studied MDR genes and monoresistance with the main clinical and morphological parameters of patients and the frequency of metastasis was established. Conclusion. The results of the study show a higher efficiency of combined treatment of NSCLC due to a significant reduction in the number of long-term metastases and local recurrences and, accordingly, improved overall and relapse-free survival. Monoresistance anMDR genes play an important role in NSCLC chemoresistance, so the study of the expression level of these genes is important for the planning of personalized treatment.

https://doi.org/10.37469/0507-3758-2019-65-3-393-398

PDF (Русский)

References

Попова Н.О., Шаталова В.А., Симолина Е.И. и др. Клинический случай длительного лечения и наблюдения пациента с метахронным раком легкого//Сибирский онкологический журнал. -2011. -T 4. -C. 75-77.

Трахтенберг А.Х., Колбанов К.И. Рак легкого//М.: ГЭ-ОТАР-Медиа, 2012. -C. 160.

Чойнзонов Е.Л., Жуйкова Л.Д., Ананина О.А. и др. Выживаемость больных раком легкого на территории Томской области (2004-2013 гг.)//Сибирский онкологический журнал. -2017. -Т. 6(4). -С. 5-10.

Юмов Е.Л., Цыганов М.М., Литвяков Н.В. и др. Экспрессия генов множественной лекарственной устойчивости и монорезистентности при немелкоклеточном раке легкого//Сибирский онкологический журнал. -2014. -Т. 61(1). -С. 16-22.

Amiri-Kordestani L., Basseville A., Kurdziel K. et al. Targeting MDR in breast and lung cancer: discriminating its potential importance from the failure of drug resistance reversal studies//Drug Resistance Update. -2012. -Vol. 15(1-2). -P. 50-61.

Douillard J., Rosell R., De Lena M. et al. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association ): a randomised controlled trial//The Lancet Oncology. -2006. -Vol. 7(9). -P 719-727.

Huang Z-L., Cao X., Luo R-Z. et al. Analysis of ERCC1, BRCA1, RRM1 and TUBB3 as predictors of prognosis in patients with non-small cell lung cancer who received cisplatin-based adjuvant chemotherapy: A prospective study//Oncology Letters. -2016. -Vol. 11(1). -P 299-305.

Litviakov N.V., Cherdyntseva N.V., Tsyganov M.M. et al. Changing the expression vector of multidrug resistance genes is related to neoadjuvant chemotherapy response//Cancer Chemotherapy and Pharmacology. -2013. -Vol. 71. -P. 153-163.

Olaussen K.A., Postel-Vinay S. Predictors of chemotherapy efficacy in non-small-cell lung cancer: a challenging landscape//Annals of Oncology. -2016. -Vol. 27(11). -P 2004-2016.

Postmus PE., Kerr K.M., Oudkerk M. et al. Early and locally advanced non-small-cell lung cancer (NsCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up//Annals of Oncology. -2017. -Vol. 28 (SUPPL_4). -P iv1-iv21.

Su C., Zhou S., Zhang L. et al. ERCC1, RRM1, and BRCA1 Mrna expression levels and clinical outcome of advanced non-small cell lung cancer//Journal of Clinical Oncology. -2010. -Vol. 28(15_suppl). -P e18045-e18045.

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Most read articles by the same author(s)

Yuliya Belevich, Yelena Simolina, Vitalina Vysotskaya, Nataliya Popova, Denis Kulbakin, Aleksey Goldberg, Zhanna Startseva, Vladimir Chernov, Irina Frolova, Svetlana Chizhevskaya, Viktor Goldberg, Yevgeniy Choynzonov, Yekaterina Dudnikova, ANTITUMOR CHEMOTHERAPY IN COMBINED TREATMENT OF PATIENTS WITH CANCER OF THE LARYNX AND HYPOPHARYNX , Voprosy onkologii : Vol. 64 No. 5 (2018)
Lyubov Tashireva, T. Gerashchenko, Yevgeniy Denisov, Olga Saveleva, Angelina Buzenkova, Marina Zavyalova, Nadezhda Cherdyntseva, Vladimir Perelmuter, CHARACTERIZATION OF THE ABILITY OF TUMOR CELLS OF VARIOUS MORPHOLOGICAL STRUCTURES TO MODULATE IMMUNE-INFLAMMATORY REACTIONS IN INVASIVE BREAST CARCINOMA , Voprosy onkologii : Vol. 66 No. 3 (2020)
Lyubov Pisareva, Nina Lyakhova, Yelena Panferova, Irina Odintsova, Olga Ananina, Tatyana Chimitdorzhieva, Artem Doroshenko, Nadezhda Cherdyntseva, D. Perinov, EPIDEMIOLOGICAL ASPECTS OF BREAST CANCER IN THE REPUBLIC OF BURYATIA. WAYS OF PREVENTION , Voprosy onkologii : Vol. 64 No. 2 (2018)
Aleksey Dobrodeev, Sergey Afanasev, Umidzhon Urmonov, Aleksandra Avgustinovich, Irina Frolova, Olga Cheremisina, A. Tarasova, RESULTS OF COMBINED MODALITY TREATMENT WITH PREOPERATIVE CHEMOTHERAPY IN ESOPHAGEAL CANCER PATIENTS , Voprosy onkologii : Vol. 66 No. 3 (2020)
Nikolay Vasilev, Vladimir Perelmuter, Yevgeniy Choynzonov, Irina Frolova, Stanislav Tabakaev, Yuriy Tyukalov, Marat Mukhamedov, Svetlana Poletaeva, P. Lyutikova, A. Maltseva, Ilya Anisenya, Anna Bogoutdinova, Pavel Sitnikov, Tikhon Serebrov, P. Bayramov, ANALYSIS OF CASES WITH LYMPHOGENOUS METASTASIS FROM CHONDROSARCOMA , Voprosy onkologii : Vol. 65 No. 5 (2019)
Lilia Zhuikova, Tatyana Polishchuk, Galina Kononova, Olga Ananina, Lidia Pikalova, Sergey Miller, Impact of COVID-19 on Lung Cancer Epidemiology in Tomsk Region , Voprosy onkologii : Vol. 69 No. 4 (2023)
Aleksey Dobrodeev, Sergey Tuzikov, Aleksandr Zavyalov, Zhanna Startseva, IMPACT OF PREOPERATIVE THERMOCHEMORADIOTHERAPY ON SURGICAL OUTCOMES IN PATIENTS WITH NON-SMALL CELL LUNG CANCER , Voprosy onkologii : Vol. 66 No. 2 (2020)
Yuliya Kzhyshkovska, Nadezhda Cherdyntseva, Sergey Tuzikov, Lyubov Pisareva, Marina Ibragimova, Sergey Miller, Irina Deryusheva, Yevgeniy Rodionov, Matvey Tsyganov, Nikolay Litvyakov, PROGNOSTIC SIGNIFICANCE OF MONORESISTANCE GENE EXPRESSION IN TUMORS OF PATIENTS WITH NON-SMALL CELL LUNG CANCER AFTER PREOPERATIVE CHEMOTHERAPY , Voprosy onkologii : Vol. 63 No. 1 (2017)
Matvey Tsyganov, Marina Ibragimova, I. Deryusheva, Yevgeniy Garbukov, Polina Kazantseva, Alina Pevzner, Yelena Slonimskaya, Nikolay Litvyakov, THE PROGNOSTIC SIGNIFICANCE OF BRCA1 GENE EXPRESSION IN PATIENTS WITH BREAST CANCER , Voprosy onkologii : Vol. 65 No. 3 (2019)